系统性红斑狼疮患者用药不依从性:一项系统综述
该系统综述检索了Medline、Embase和Web of Science数据库,纳入11项评估SLE患者用药不依从性的原始研究。研究显示不依从患者比例范围为43%至75%,超过半数患者不依从,高达33%的患者在5年后停药。不依从的决定因素包括抑郁、农村居住、较低教育程度和多重用药。
要点
- SLE患者用药不依从负担显著,各研究一致报告超过半数患者不依从。
- 不依从比例范围为43%至75%,高达33%的患者在5年后停药。
- 抑郁、农村居住、较低教育程度和多重用药是不依从的决定因素。
核心结论
- 当前证据综合表明SLE患者用药不依从负担显著,需开发支持依从性的干预措施以改善结局。
研究设计与样本
- 系统检索Medline(1946-2015)、Embase(1974-2015)和Web of Science(1900-2015)数据库,筛选以SLE治疗不依从为主要结局的原始研究。
- 共筛查4111条标题,最终纳入11项研究,样本量范围为32至246例患者。
- 数据来源分类:自我报告5项、电子监测设备1项、风湿科门诊临床记录3项、药房记录续药信息2项。
主要发现
- 不依从患者百分比范围为43%至75%,各研究一致报告超过半数患者不依从。
- 高达33%的患者在5年后停止治疗。
- 不依从的决定因素包括抑郁、农村居住、较低教育程度和多重用药。
临床怎么用
- 风湿免疫科医生应关注SLE患者用药不依从问题,尤其对合并抑郁、农村居住、较低教育程度或多重用药的患者加强依从性评估与支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Medication nonadherence has not been well characterized in systemic lupus erythematosus (SLE). Our objective was to a conduct a systematic review of the literature, examining the burden and determinants of medication nonadherence in SLE. METHODS: We conducted a systematic search of Medline (1946-2015), Embase (1974-2015), and Web of Science (1900-2015) databases and selected original studies of SLE patients that evaluated nonadherence to SLE therapies as the primary study outcome. We extracted information on study design, sample size, length of followup, data sources, type of nonadherence problem examined, adherence measures and reported estimates, and determinants of adherence reported in multivariable analyses. RESULTS: After screening 4,111 titles, 11 studies met the inclusion criteria. Study sample sizes ranged from 32 to 246 patients, and studies were categorized according to data source: self-report (5), electronic monitoring devices (1), clinical records from rheumatology clinics (3), and refill information from pharmacy records (2). Overall, the percentage of nonadherent patients ranged from 43% to 75%, with studies consistently reporting that over half of patients are nonadherent. Studies also showed that up to 33% of patients discontinue therapy after 5 years. Determinants of nonadherence included having depression, rural residence, lower education level, and polypharmacy. CONCLUSION: Overall, synthesis of current evidence suggests that the burden of medication nonadherence is substantial in SLE. Findings highlight the importance of developing interventions to support adherence and improve outcomes among patients.
引用
- Mehat P, Atiquzzaman M, Esdaile JM, et al. Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review. Arthritis Care Res (Hoboken). 2017. PMID: 28086003. doi:10.1002/acr.23191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。